As part of the National Resident Matching Program, fourth-year medical students at Mayo Clinic Alix School of Medicine and ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

Charlotte’s first medical school and the Pearl Innovation District are taking shape. Atrium Health’s med school, innovation ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...

This came after Zydus Lifesciences presented a bioequivalence study report ... She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology ...

The discussions emphasised the evolving landscape of acute liver failure, sepsis in chronic liver disease, and post-transplant critical care The Tribune, now published from Chandigarh, started ...

Zydus Lifesciences has launched VaxiFlu-4, India’s first quadrivalent flu vaccine to offer better protection against influenza A and B strains. Experts stress the importance of vaccination and ...

Zydus Lifesciences on Wednesday (February 26 ... and people with immunosuppressive and chronic medical conditions. According to the World Health Organisation, seasonal influenza results in ...

(Image Credits: Freepik) Zydus on Wednesday announced that it is ... and people with immunosuppressive and chronic medical conditions. According to the World Health Organization (WHO), seasonal ...

Ahmedabad-based Zydus Lifesciences is set to launch the vaccine VaxiFlu-4 to combat a new strain of the influenza virus, as per the WHO-recommended composition of quadrivalent influenza virus ...